NEUROCRINE BIOSCIENCES INC Amortization of Debt Issuance Costs
NEUROCRINE BIOSCIENCES INC (NBIX) reported Amortization of Debt Issuance Costs of $700.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-02-09
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for the quarter ending 2023-12-31 was $100.00K, a 50.00% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for the quarter ending 2023-09-30 was $200.00K, a 0.00% change year-over-year.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for the quarter ending 2023-06-30 was $200.00K, a 50.00% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for the quarter ending 2023-03-31 was $200.00K, a 50.00% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for fiscal 2023 was $700.00K, a 41.67% decline from fiscal 2022.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for fiscal 2022 was $1.20M, a 9.09% increase from fiscal 2021.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for fiscal 2021 was $1.10M, a 21.43% decline from fiscal 2020.
- NEUROCRINE BIOSCIENCES INC amortization of debt issuance costs for fiscal 2020 was $1.40M, a 0.00% change from fiscal 2019.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 6 month as first filed | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 9 month as first filed | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $300.00K derived: sum of 2 quarters · filed 2024-02-09 | $500.00K derived: sum of 3 quarters · filed 2024-02-09 | $700.00K 10-K · filed 2024-02-09 | ||||
| 2023-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $400.00K derived: sum of 2 quarters · filed 2023-10-31 | $600.00K 10-Q · filed 2023-10-31 | $800.00K derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2023-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $400.00K 10-Q · filed 2023-08-01 | $600.00K derived: sum of 3 quarters · filed 2024-02-09 | $800.00K derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-03 | $400.00K derived: sum of 2 quarters · filed 2024-02-09 | $600.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.00M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $400.00K derived: sum of 2 quarters · filed 2024-02-09 | $800.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.20M 10-K · filed 2024-02-09 | ||||
| 2022-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $600.00K derived: sum of 2 quarters · filed 2023-10-31 | $1.00M 10-Q · filed 2023-10-31 | $1.30M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $800.00K 10-Q · filed 2023-08-01 | $1.10M derived: sum of 3 quarters · filed 2024-02-09 | $1.30M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-03 | $700.00K derived: sum of 2 quarters · filed 2024-02-09 | $900.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.20M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $500.00K derived: sum of 2 quarters · filed 2024-02-09 | $800.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.10M 10-K · filed 2024-02-09 | ||||
| 2021-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $500.00K derived: sum of 2 quarters · filed 2022-11-01 | $800.00K 10-Q · filed 2022-11-01 | $1.20M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $600.00K 10-Q · filed 2022-08-04 | $1.00M derived: sum of 3 quarters · filed 2023-02-09 | $1.30M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-04 | $700.00K derived: sum of 2 quarters · filed 2023-02-09 | $1.00M derived: sum of 3 quarters · filed 2023-02-09 | $1.40M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $700.00K derived: sum of 2 quarters · filed 2023-02-09 | $1.10M derived: sum of 3 quarters · filed 2023-02-09 | $1.40M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $700.00K derived: sum of 2 quarters · filed 2021-11-01 | $1.00M 10-Q · filed 2021-11-01 | $1.40M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $700.00K 10-Q · filed 2021-08-03 | $1.10M derived: sum of 3 quarters · filed 2022-02-11 | $1.40M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-05 | $700.00K derived: sum of 2 quarters · filed 2022-02-11 | $1.00M derived: sum of 3 quarters · filed 2022-02-11 | $1.40M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $700.00K derived: sum of 2 quarters · filed 2022-02-11 | $1.10M derived: sum of 3 quarters · filed 2022-02-11 | $1.40M 10-K · filed 2022-02-11 | $1.39M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $700.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.00M 10-Q · filed 2020-11-09 | $1.04M 10-Q · filed 2019-11-04 | $1.31M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $700.00K 10-Q · filed 2020-08-03 | $687.00K 10-Q · filed 2019-07-29 | $1.01M derived: sum of 3 quarters · filed 2021-02-05 | $1.34M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-03-31 | $300.00K 10-Q · filed 2020-05-06 | $341.00K 10-Q · filed 2019-04-29 | $611.00K derived: sum of 2 quarters · filed 2021-02-05 | $945.00K derived: sum of 3 quarters · filed 2021-02-05 | $1.27M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2018-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-05 | $645.00K derived: sum of 2 quarters · filed 2021-02-05 | $974.00K derived: sum of 3 quarters · filed 2021-02-05 | $1.30M 10-K · filed 2021-02-05 | $1.33M 10-K · filed 2019-02-08 | |||
| 2018-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $663.00K derived: sum of 2 quarters · filed 2019-11-04 | $989.00K 10-Q · filed 2019-11-04 | $1.31M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $655.00K 10-Q · filed 2019-07-29 | $977.00K derived: sum of 3 quarters · filed 2020-02-07 | $1.30M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | $326.00K 10-Q · filed 2019-04-29 | $648.00K derived: sum of 2 quarters · filed 2020-02-07 | $967.00K derived: sum of 3 quarters · filed 2020-02-07 | $1.17M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2017-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $641.00K derived: sum of 2 quarters · filed 2020-02-07 | $848.00K derived: sum of 3 quarters · filed 2020-02-07 | $848.00K 10-K · filed 2020-02-07 | ||||
| 2017-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $526.00K derived: sum of 2 quarters · filed 2018-11-05 | $526.00K 10-Q · filed 2018-11-05 | $526.00K derived: sum of 4 quarters · filed 2019-02-08 | ||||
| 2017-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $207.00K 10-Q · filed 2018-07-31 | $207.00K derived: sum of 3 quarters · filed 2019-02-08 | $207.00K derived: sum of 4 quarters · filed 2019-02-08 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-04-30 | $0.00 derived: sum of 2 quarters · filed 2019-02-08 | $0.00 derived: sum of 3 quarters · filed 2019-02-08 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | $0.00 derived: sum of 2 quarters · filed 2019-02-08 | $0.00 10-K · filed 2019-02-08 | |||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | ||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | |||||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |